Skip to content

Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms

Investigating Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms: An Exploratory Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01543997
Enrollment
75
Registered
2012-03-05
Start date
2012-01-31
Completion date
2016-05-31
Last updated
2016-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persian Gulf War Syndrome in Veteran, Sleep Disturbance

Brief summary

The purpose of this study is to investigate clinical benefits of a novel sleep-focused mind-body program on Gulf War Illness (GWI) symptoms.

Detailed description

This randomized study investigates whether two treatment conditions:Mind-Body Bridging (MBB) and Supportive Education (SED) are effective in improving sleep disturbance and self-reported indicators of other co-morbid symptoms in veterans with GWI. The two treatment conditions will each comprise 3 sessions of 2 hr. duration and conducted over 3 consecutive weeks (Week 1-3).

Interventions

Bridging aims to reduce the impact of negative thought patterns that contribute to stress in the body.

This intervention will provide educational lectures on disability, sleep hygiene, and current research on depression and nondirective, supportive discussions about these topics.

Sponsors

VA Salt Lake City Health Care System
CollaboratorFED
United States Department of Defense
CollaboratorFED
University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
38 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Veteran from First Gulf War * Suffering from sleep disturbance * Has other chronic symptoms of Gulf War Illness: * fatigue * chronic headaches * joint/muscle pain * cognitive difficulties * memory/concentration problems * shortness of breath * gastrointestinal symptoms

Exclusion criteria

* terminally ill * a highly unstable medical or psychiatric condition * Parkinson disease * dementia of any cause * Nocturia * delayed/advanced sleep phase syndrome * Narcolepsy

Design outcomes

Primary

MeasureTime frame
Change from baseline in the measure of the Medical Outcomes Study-Sleep ScaleWeek1, Week2, Week 3, Week 4, Week 15
Change from baseline in the measure of the Sleep DiaryWeek2, Week 4, Week 15

Secondary

MeasureTime frameDescription
Cognitive functioningPre (Baseline), Post (Week4), Follow-up (Week 15)Cognitive Failures Questionnaire
MindfulnessPre (Baseline), Weekly for 3 weeks, Post (Week4), Follow-up (Week 15)5-factor M questionnaire
Health-related quality of lifePre (Baseline), Post (Week4), Follow-up (Week 15)Medical Outcomes Study Short Form-36
PainPre (Baseline), Post (Week4), Follow-up (Week 15)Multidimensional Pain Inventory Pain Scale
DepressionPre (Baseline), Post (Week4), Follow-up (Week 15)Center of Epidemiological Study-Depression Scale
Psychological symptomsPre (Baseline), Post (Week4), Follow-up (Week 15)Brief Symptom Inventory 18
PTSDPre (Baseline), Post (Week4), Follow-up (Week 15)PTSD Check List-Military (PCL-M)
FatiguePre (Baseline), Post (Week4), Follow-up (Week 15)Multidimensional Fatigue Inventory

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026